However on univariate analysis, positive RUNX1 expression was significantly associated with poorer cancer-specific survival in the ER− (P<0.05) and triple negative (ER−/PR−/HER2−) (P<0.05) groups of patients. This evidence concerns the gene ERBB2 and cancer.